Article
The microbial derived bile acid lithocholate and its epimers inhibit Clostridioides…
medRxiv · 2023 · Kisthardt, S. C.; Thanissery, R.; Pike, C. M.; Foley, M. H.; Theriot, C. M.
Key facts
| Title | The microbial derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota |
|---|---|
| First author | Kisthardt, S. C.; Thanissery, R.; Pike, C. M.; Foley, M. H.; Theriot, C. M. |
| Journal | medRxiv |
| Published | Jun 7, 2023 |
| DOI | 10.1101/2023.06.06.543867 |
| Devices mentioned | 211059 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1